Gene ontology annotations for RPLP1 |
|
Experiment description of studies that identified RPLP1 in exosomes |
1 |
Experiment ID |
489 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
Cd9|Cd81|Cd63|Gapdh|Sdcbp|Lamp1|Aqp1|Rab5a|Icam1|Cd82|Itga2b|Tsg101|Lamp2|Rab35|Flot1|Flot2|Cd151|Rab5b|Tfrc|Uchl1
|
Enriched markers |
✔
Canx
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
Protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
36408942
|
Organism |
Rattus norvegicus |
Experiment description |
Quantitative proteomic analysis of exosomes from umbilical cord mesenchymal stem cells and rat bone marrow stem cells |
Authors |
"Xu X, Yin F, Guo M, Gan G, Lin G, Wen C, Wang J, Song P, Wang J, Qi ZQ, Zhong CQ." |
Journal name |
Proteomics
|
Publication year |
2023 |
Sample |
Bone marrow mesenchymal stem cells |
Sample name |
BMSC - Passage 6 |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectometry |
|
|
2 |
Experiment ID |
490 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
Cd9|Cd81|Cd63|Gapdh|Sdcbp|Lamp1|Aqp1|Rab5a|Icam1|Cd82|Itga2b|Tsg101|Lamp2|Rab35|Flot1|Flot2|Cd151|Rab5b|Tfrc|Uchl1
|
Enriched markers |
✔
Canx
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
Protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
36408942
|
Organism |
Rattus norvegicus |
Experiment description |
Quantitative proteomic analysis of exosomes from umbilical cord mesenchymal stem cells and rat bone marrow stem cells |
Authors |
"Xu X, Yin F, Guo M, Gan G, Lin G, Wen C, Wang J, Song P, Wang J, Qi ZQ, Zhong CQ." |
Journal name |
Proteomics
|
Publication year |
2023 |
Sample |
Bone marrow mesenchymal stem cells |
Sample name |
BMSC - Passage 7 |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectometry |
|
|
3 |
Experiment ID |
491 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
Cd9|Cd81|Cd63|Gapdh|Sdcbp|Lamp1|Aqp1|Rab5a|Icam1|Cd82|Itga2b|Tsg101|Lamp2|Rab35|Flot1|Flot2|Cd151|Rab5b|Tfrc|Uchl1
|
Enriched markers |
✔
Canx
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
Protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
36408942
|
Organism |
Rattus norvegicus |
Experiment description |
Quantitative proteomic analysis of exosomes from umbilical cord mesenchymal stem cells and rat bone marrow stem cells |
Authors |
"Xu X, Yin F, Guo M, Gan G, Lin G, Wen C, Wang J, Song P, Wang J, Qi ZQ, Zhong CQ." |
Journal name |
Proteomics
|
Publication year |
2023 |
Sample |
Bone marrow mesenchymal stem cells |
Sample name |
BMSC - Passage 8 |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectometry |
|
|
4 |
Experiment ID |
492 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
Cd9|Cd81|Cd63|Gapdh|Sdcbp|Lamp1|Aqp1|Rab5a|Icam1|Cd82|Itga2b|Tsg101|Lamp2|Rab35|Flot1|Flot2|Cd151|Rab5b|Tfrc|Uchl1
|
Enriched markers |
✔
Canx
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
Protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
36408942
|
Organism |
Rattus norvegicus |
Experiment description |
Quantitative proteomic analysis of exosomes from umbilical cord mesenchymal stem cells and rat bone marrow stem cells |
Authors |
"Xu X, Yin F, Guo M, Gan G, Lin G, Wen C, Wang J, Song P, Wang J, Qi ZQ, Zhong CQ." |
Journal name |
Proteomics
|
Publication year |
2023 |
Sample |
Bone marrow mesenchymal stem cells |
Sample name |
BMSC - Passage 9 |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectometry |
|
|
5 |
Experiment ID |
497 |
MISEV standards |
✘
|
Biophysical techniques |
✔
CD9|CD151|CD63|CD81|CD82|FLOT1|FLOT2|GAPDH|LAMP1|LAMP2|RAB5A|SDCBP|TFRC|TSG101|UCHL1
|
Enriched markers |
✘
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
Protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
35931686
|
Organism |
Homo sapiens |
Experiment description |
Extracellular vesicles enriched in connexin 43 promote a senescent phenotype in bone and synovial cells contributing to osteoarthritis progression |
Authors |
"Varela-EirÃÂn M, Carpintero-Fernández P, Guitián-Caamaño A, Varela-Vázquez A, GarcÃÂa-Yuste A, Sánchez-Temprano A, Bravo-López SB, Yañez-Cabanas J, Fonseca E, Largo R, Mobasheri A, Caeiro JR, Mayán MD." |
Journal name |
Cell Death Dis
|
Publication year |
2022 |
Sample |
Chondrocytes |
Sample name |
T/C-28a2 |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectometry |
|
|
6 |
Experiment ID |
498 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
CD9|CD151|CD63|CD81|CD82|FLOT1|FLOT2|GAPDH|LAMP1|LAMP2|RAB5A|SDCBP|TFRC|TSG101|UCHL1
|
Enriched markers |
✘
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
Protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
35931686
|
Organism |
Homo sapiens |
Experiment description |
Extracellular vesicles enriched in connexin 43 promote a senescent phenotype in bone and synovial cells contributing to osteoarthritis progression |
Authors |
"Varela-EirÃÂn M, Carpintero-Fernández P, Guitián-Caamaño A, Varela-Vázquez A, GarcÃÂa-Yuste A, Sánchez-Temprano A, Bravo-López SB, Yañez-Cabanas J, Fonseca E, Largo R, Mobasheri A, Caeiro JR, Mayán MD." |
Journal name |
Cell Death Dis
|
Publication year |
2022 |
Sample |
Chondrocytes |
Sample name |
T/C-28a2 |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectometry |
|
|
7 |
Experiment ID |
20 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
HSP90|CD63|CD81|LAMP1
|
Enriched markers |
✔
GOLGA2|cytochrome c
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
17956143
|
Organism |
Homo sapiens |
Experiment description |
Proteomic analysis of microvesicles derived from human colorectal cancer cells. |
Authors |
"Choi DS, Lee JM, Park GW, Lim HW, Bang JY, Kim YK, Kwon KH, Kwon HJ, Kim KP, Gho YS" |
Journal name |
JPR
|
Publication year |
2007 |
Sample |
Colorectal cancer cells |
Sample name |
HT29 |
Isolation/purification methods |
Differential centrifugation Sucrose density gradient Diafiltration |
Flotation density |
1.16 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry [LTQ] Western blotting |
|
|
8 |
Experiment ID |
1203 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
SDCBP|FLOT1|CD9|CD81|CD63|EPCAM|GAPDH|LAMP1|TFRC|CD151|CD82|LAMP2|RAB35|TSG101|FLOT2|RAB5B|ICAM1|RAB5A
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
34887515
|
Organism |
Homo sapiens |
Experiment description |
Supermeres are functional extracellular nanoparticles replete with disease biomarkers and therapeutic targets |
Authors |
"Zhang Q, Jeppesen DK, Higginbotham JN, Graves-Deal R, Trinh VQ, Ramirez MA, Sohn Y, Neininger AC, Taneja N, McKinley ET, Niitsu H, Cao Z, Evans R, Glass SE, Ray KC, Fissell WH, Hill S, Rose KL, Huh WJ, Washington MK, Ayers GD, Burnette DT, Sharma S, Rome LH, Franklin JL, Lee YA, Liu Q, Coffey RJ." |
Journal name |
Nat Cell Biol
|
Publication year |
2021 |
Sample |
Colorectal cancer cells |
Sample name |
DiFi |
Isolation/purification methods |
Differential centrifugation Filtration Centrifugal ultrafiltration Ultracentrifugation OptiPrep density gradient centrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein miRNA |
Methods used in the study |
Western blotting Mass spectrometry RNA sequencing |
|
|
9 |
Experiment ID |
363 |
MISEV standards |
✘
|
Biophysical techniques |
✔
TSG101|GAPDH|AQP1|CD151|CD81|CD82|CD9|EPCAM|FLOT1|FLOT2|ICAM1|ITGA2B|LAMP2|RAB35|RAB5A|RAB5B|SDCBP|TFRC|UCHL1
|
Enriched markers |
✔
DCLK1
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
Protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
33991177
|
Organism |
Homo sapiens |
Experiment description |
Cancer stem cell marker DCLK1 reprograms small extracellular vesicles toward migratory phenotype in gastric cancer cells |
Authors |
"Carli ALE, Afshar-Sterle S, Rai A, Fang H, O'Keefe R, Tse J, Ferguson FM, Gray NS, Ernst M, Greening DW, Buchert M." |
Journal name |
Proteomics
|
Publication year |
2021 |
Sample |
Gastric cancer cells |
Sample name |
MKN1 - 100K pellet |
Isolation/purification methods |
Differential centrifugation Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectrometry |
|
|
10 |
Experiment ID |
364 |
MISEV standards |
✘
|
Biophysical techniques |
✔
TSG101|GAPDH|AQP1|CD151|CD81|CD82|CD9|EPCAM|FLOT1|FLOT2|ICAM1|ITGA2B|LAMP2|RAB35|RAB5A|RAB5B|SDCBP|TFRC|UCHL1
|
Enriched markers |
✔
DCLK1
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
Protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
33991177
|
Organism |
Homo sapiens |
Experiment description |
Cancer stem cell marker DCLK1 reprograms small extracellular vesicles toward migratory phenotype in gastric cancer cells |
Authors |
"Carli ALE, Afshar-Sterle S, Rai A, Fang H, O'Keefe R, Tse J, Ferguson FM, Gray NS, Ernst M, Greening DW, Buchert M." |
Journal name |
Proteomics
|
Publication year |
2021 |
Sample |
Gastric cancer cells |
Sample name |
MKN1 - 100K pellet |
Isolation/purification methods |
Differential centrifugation Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectrometry |
|
|
11 |
Experiment ID |
365 |
MISEV standards |
✘
|
Biophysical techniques |
✔
TSG101|GAPDH|AQP1|CD151|CD81|CD82|CD9|EPCAM|FLOT1|FLOT2|ICAM1|ITGA2B|LAMP2|RAB35|RAB5A|RAB5B|SDCBP|TFRC|UCHL1
|
Enriched markers |
✔
DCLK1
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
Protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
33991177
|
Organism |
Homo sapiens |
Experiment description |
Cancer stem cell marker DCLK1 reprograms small extracellular vesicles toward migratory phenotype in gastric cancer cells |
Authors |
"Carli ALE, Afshar-Sterle S, Rai A, Fang H, O'Keefe R, Tse J, Ferguson FM, Gray NS, Ernst M, Greening DW, Buchert M." |
Journal name |
Proteomics
|
Publication year |
2021 |
Sample |
Gastric cancer cells |
Sample name |
MKN1 - 100K pellet |
Isolation/purification methods |
Differential centrifugation Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectrometry |
|
|
12 |
Experiment ID |
234 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
TSG101|Alix|HSC70|GAPDH
|
Enriched markers |
✔
HSP90B1
|
Negative markers |
✔
qNano
|
Particle analysis
|
|
Identified molecule |
mRNA
|
Identification method |
RNA Sequencing
|
PubMed ID |
26054723
|
Organism |
Homo sapiens |
Experiment description |
Hepatocellular carcinoma-derived exosomes promote motility of immortalized hepatocyte through transfer of oncogenic proteins and RNAs |
Authors |
"He M, Qin H, Poon TC, Sze SC, Ding X, Co NN, Ngai SM, Chan TF, Wong N" |
Journal name |
Carcinogenesis
|
Publication year |
2015 |
Sample |
Hepatocellular carcinoma cells |
Sample name |
HKCI-C3 |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation Sucrose density gradient |
Flotation density |
1.13-1.19 g/mL
|
Molecules identified in the study |
Protein RNA |
Methods used in the study |
Western blotting Mass spectrometry RT-PCR RNA Sequencing |
|
|
13 |
Experiment ID |
235 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
TSG101|Alix|HSC70|GAPDH
|
Enriched markers |
✔
HSP90B1
|
Negative markers |
✔
qNano
|
Particle analysis
|
|
Identified molecule |
mRNA
|
Identification method |
RNA Sequencing
|
PubMed ID |
26054723
|
Organism |
Homo sapiens |
Experiment description |
Hepatocellular carcinoma-derived exosomes promote motility of immortalized hepatocyte through transfer of oncogenic proteins and RNAs |
Authors |
"He M, Qin H, Poon TC, Sze SC, Ding X, Co NN, Ngai SM, Chan TF, Wong N" |
Journal name |
Carcinogenesis
|
Publication year |
2015 |
Sample |
Hepatocellular carcinoma cells |
Sample name |
HKCI-8 |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation Sucrose density gradient |
Flotation density |
1.13-1.19 g/mL
|
Molecules identified in the study |
Protein RNA |
Methods used in the study |
Western blotting Mass spectrometry RT-PCR RNA Sequencing |
|
|
14 |
Experiment ID |
236 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
TSG101|Alix|HSC70|GAPDH
|
Enriched markers |
✔
HSP90B1
|
Negative markers |
✔
qNano
|
Particle analysis
|
|
Identified molecule |
mRNA
|
Identification method |
RNA Sequencing
|
PubMed ID |
26054723
|
Organism |
Homo sapiens |
Experiment description |
Hepatocellular carcinoma-derived exosomes promote motility of immortalized hepatocyte through transfer of oncogenic proteins and RNAs |
Authors |
"He M, Qin H, Poon TC, Sze SC, Ding X, Co NN, Ngai SM, Chan TF, Wong N" |
Journal name |
Carcinogenesis
|
Publication year |
2015 |
Sample |
Hepatocellular carcinoma cells |
Sample name |
MHCC97L |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation Sucrose density gradient |
Flotation density |
1.13-1.19 g/mL
|
Molecules identified in the study |
Protein RNA |
Methods used in the study |
Western blotting Mass spectrometry RT-PCR RNA Sequencing |
|
|
15 |
Experiment ID |
237 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
TSG101|Alix|HSC70|GAPDH
|
Enriched markers |
✔
HSP90B1
|
Negative markers |
✔
qNano
|
Particle analysis
|
|
Identified molecule |
mRNA
|
Identification method |
RNA Sequencing
|
PubMed ID |
26054723
|
Organism |
Homo sapiens |
Experiment description |
Hepatocellular carcinoma-derived exosomes promote motility of immortalized hepatocyte through transfer of oncogenic proteins and RNAs |
Authors |
"He M, Qin H, Poon TC, Sze SC, Ding X, Co NN, Ngai SM, Chan TF, Wong N" |
Journal name |
Carcinogenesis
|
Publication year |
2015 |
Sample |
Hepatocytes |
Sample name |
MIHA |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation Sucrose density gradient |
Flotation density |
1.13-1.19 g/mL
|
Molecules identified in the study |
Protein RNA |
Methods used in the study |
Western blotting Mass spectrometry RNA Sequencing |
|
|
16 |
Experiment ID |
488 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
CD9|CD81|CD63|GAPDH|SDCBP|LAMP1|TFRC|UCHL1|FLOT2|LAMP2|FLOT1|ICAM1|RAB5B|CD151|RAB35|TSG101|RAB5A|CD82
|
Enriched markers |
✔
CANX
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
Protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
36408942
|
Organism |
Homo sapiens |
Experiment description |
Quantitative proteomic analysis of exosomes from umbilical cord mesenchymal stem cells and rat bone marrow stem cells |
Authors |
"Xu X, Yin F, Guo M, Gan G, Lin G, Wen C, Wang J, Song P, Wang J, Qi ZQ, Zhong CQ." |
Journal name |
Proteomics
|
Publication year |
2023 |
Sample |
Mesenchymal stem cells |
Sample name |
UCMSC |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectometry |
|
|
17 |
Experiment ID |
275 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
TSG101|Alix|RAB5A|CD9|CD82|CD63|CD81
|
Enriched markers |
✔
AIF
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
25844599
|
Organism |
Homo sapiens |
Experiment description |
Molecular profiling of prostate cancer derived exosomes may reveal a predictive signature for response to docetaxel. |
Authors |
"Kharaziha P, Chioureas D, Rutishauser D, Baltatzis G, Lennartsson L, Fonseca P, Azimi A, Hultenby K, Zubarev R, Ullen A, Yachnin J, Nilsson S, Panaretakis T." |
Journal name |
Oncotarget
|
Publication year |
2015 |
Sample |
Prostate cancer cells |
Sample name |
DU145 - Docetaxel sensitive |
Isolation/purification methods |
Filtration Ultracentrifugation Sucrose density gradient |
Flotation density |
1.12-1.19 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry/Flow cytometry/Western blotting |
|
|
18 |
Experiment ID |
274 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
TSG101|Alix|RAB5A|CD9|CD82|CD63|CD81
|
Enriched markers |
✔
AIF
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
25844599
|
Organism |
Homo sapiens |
Experiment description |
Molecular profiling of prostate cancer derived exosomes may reveal a predictive signature for response to docetaxel. |
Authors |
"Kharaziha P, Chioureas D, Rutishauser D, Baltatzis G, Lennartsson L, Fonseca P, Azimi A, Hultenby K, Zubarev R, Ullen A, Yachnin J, Nilsson S, Panaretakis T." |
Journal name |
Oncotarget
|
Publication year |
2015 |
Sample |
Prostate cancer cells |
Sample name |
DU145 - Docetaxel resistant |
Isolation/purification methods |
Filtration Ultracentrifugation Sucrose density gradient |
Flotation density |
1.13-1.18 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry Flow cytometry Western blotting |
|
|
19 |
Experiment ID |
217 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
TSG101|CD81|CD9|CD63
|
Enriched markers |
✘
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
23844026
|
Organism |
Homo sapiens |
Experiment description |
Characterization of human thymic exosomes. |
Authors |
"Skogberg G, Gudmundsdottir J, van der Post S, Sandstrom K, Bruhn S, Benson M, Mincheva-Nilsson L, Baranov V, Telemo E, Ekwall O." |
Journal name |
PLoS One
|
Publication year |
2013 |
Sample |
Thymus |
Sample name |
Normal-Thymus |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
Protein-protein interactions for RPLP1 |
|
Protein Interactor |
ExoCarta ID |
Identification method |
PubMed |
Species |
1 |
RPL11 |
6135 |
Co-fractionation |
|
Homo sapiens |
Co-fractionation |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
Co-fractionation |
|
Homo sapiens |
|
2 |
EIF3A |
8661 |
Co-fractionation |
|
Homo sapiens |
|
3 |
EMC4 |
51234 |
Affinity Capture-MS |
|
Homo sapiens |
|
4 |
ZNF668 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
5 |
HNRNPH1 |
3187 |
Affinity Capture-MS |
|
Homo sapiens |
|
6 |
IGF2BP1 |
10642 |
Affinity Capture-MS |
|
Homo sapiens |
|
7 |
UBL4A |
8266 |
Affinity Capture-MS |
|
Homo sapiens |
|
8 |
ZNF346 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
9 |
EIF2S3 |
1968 |
Affinity Capture-MS |
|
Homo sapiens |
|
10 |
RPL30 |
6156 |
Co-fractionation |
|
Homo sapiens |
|
11 |
RIN3 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
12 |
SSB |
6741 |
Affinity Capture-MS |
|
Homo sapiens |
|
13 |
RPA2 |
6118 |
Two-hybrid |
|
Homo sapiens |
|
14 |
CD4 |
920 |
Affinity Capture-MS |
|
Homo sapiens |
|
15 |
RPL13A |
23521 |
Affinity Capture-MS |
|
Homo sapiens |
|
16 |
ADRB2 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
17 |
G3BP1 |
10146 |
Affinity Capture-MS |
|
Homo sapiens |
|
18 |
ACTC1 |
70 |
Affinity Capture-MS |
|
Homo sapiens |
|
19 |
RPL37A |
6168 |
Co-fractionation |
|
Homo sapiens |
|
20 |
RPS19 |
6223 |
Co-fractionation |
|
Homo sapiens |
Co-fractionation |
|
Homo sapiens |
|
21 |
RPL10 |
6134 |
Co-fractionation |
|
Homo sapiens |
|
22 |
RPL15 |
6138 |
Co-fractionation |
|
Homo sapiens |
|
23 |
TAB1 |
10454 |
Two-hybrid |
|
Homo sapiens |
|
24 |
RPL14 |
9045 |
Affinity Capture-MS |
|
Homo sapiens |
Co-fractionation |
|
Homo sapiens |
|
25 |
CSNK2A1 |
1457 |
Biochemical Activity |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
26 |
CAND1 |
55832 |
Affinity Capture-MS |
|
Homo sapiens |
|
27 |
RPS17 |
6218 |
Co-fractionation |
|
Homo sapiens |
|
28 |
RPS3 |
6188 |
Co-fractionation |
|
Homo sapiens |
Co-fractionation |
|
Homo sapiens |
|
29 |
RB1CC1 |
9821 |
Affinity Capture-MS |
|
Homo sapiens |
|
30 |
ATG13 |
9776 |
Affinity Capture-MS |
|
Homo sapiens |
|
31 |
MAP1LC3B |
81631 |
Two-hybrid |
|
Homo sapiens |
|
32 |
MRPS35 |
60488 |
Co-fractionation |
|
Homo sapiens |
|
33 |
CAPZB |
832 |
Affinity Capture-MS |
|
Homo sapiens |
|
34 |
PARK2 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
35 |
RPS20 |
6224 |
Co-fractionation |
|
Homo sapiens |
|
36 |
METAP2 |
10988 |
Affinity Capture-MS |
|
Homo sapiens |
|
37 |
IGBP1 |
3476 |
Co-fractionation |
|
Homo sapiens |
|
38 |
PRC1 |
9055 |
Affinity Capture-MS |
|
Homo sapiens |
|
39 |
KIF23 |
9493 |
Affinity Capture-MS |
|
Homo sapiens |
|
40 |
UBE2O |
63893 |
Affinity Capture-MS |
|
Homo sapiens |
|
41 |
COPS6 |
10980 |
Affinity Capture-MS |
|
Homo sapiens |
|
42 |
COPS5 |
10987 |
Affinity Capture-MS |
|
Homo sapiens |
|
43 |
FBXW7 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
44 |
RPL24 |
6152 |
Co-fractionation |
|
Homo sapiens |
|
45 |
NUDT3 |
11165 |
Two-hybrid |
|
Homo sapiens |
Two-hybrid |
|
Homo sapiens |
|
46 |
CALD1 |
800 |
Affinity Capture-MS |
|
Homo sapiens |
|
47 |
NPM1 |
4869 |
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
48 |
KATNAL2 |
83473 |
Co-fractionation |
|
Homo sapiens |
|
49 |
RRS1 |
23212 |
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
50 |
RPS8 |
6202 |
Co-fractionation |
|
Homo sapiens |
Co-fractionation |
|
Homo sapiens |
|
51 |
SRP19 |
6728 |
Affinity Capture-MS |
|
Homo sapiens |
|
52 |
DDX58 |
23586 |
Affinity Capture-RNA |
|
Homo sapiens |
|
53 |
GSPT1 |
2935 |
Affinity Capture-MS |
|
Homo sapiens |
|
54 |
ADARB1 |
104 |
Affinity Capture-MS |
|
Homo sapiens |
|
55 |
PRKRA |
8575 |
Affinity Capture-MS |
|
Homo sapiens |
|
56 |
SRP68 |
6730 |
Affinity Capture-MS |
|
Homo sapiens |
|
57 |
RPL29 |
6159 |
Co-fractionation |
|
Homo sapiens |
Co-fractionation |
|
Homo sapiens |
|
58 |
ATG16L1 |
55054 |
Affinity Capture-MS |
|
Homo sapiens |
|
59 |
DDX6 |
1656 |
Affinity Capture-MS |
|
Homo sapiens |
|
60 |
RPS3A |
6189 |
Co-fractionation |
|
Homo sapiens |
Co-fractionation |
|
Homo sapiens |
|
61 |
MPC2 |
25874 |
Two-hybrid |
|
Homo sapiens |
|
62 |
CUL1 |
8454 |
Affinity Capture-MS |
|
Homo sapiens |
|
63 |
KDM4D |
|
Affinity Capture-MS |
|
Homo sapiens |
|
64 |
ARIH2 |
10425 |
Affinity Capture-MS |
|
Homo sapiens |
|
65 |
RBM42 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
66 |
RPS11 |
6205 |
Co-fractionation |
|
Homo sapiens |
|
67 |
RPL19 |
6143 |
Co-fractionation |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
Co-fractionation |
|
Homo sapiens |
|
68 |
GSK3B |
2932 |
Two-hybrid |
|
Homo sapiens |
|
69 |
KIF14 |
9928 |
Affinity Capture-MS |
|
Homo sapiens |
|
70 |
TPT1 |
7178 |
Two-hybrid |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
71 |
EMC9 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
72 |
TRIM31 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
73 |
PDZD8 |
118987 |
Affinity Capture-MS |
|
Homo sapiens |
|
74 |
CHMP4C |
92421 |
Affinity Capture-MS |
|
Homo sapiens |
|
75 |
RPS23 |
6228 |
Co-fractionation |
|
Homo sapiens |
Co-fractionation |
|
Homo sapiens |
|
76 |
RPL27 |
6155 |
Co-fractionation |
|
Homo sapiens |
|
77 |
VRK3 |
51231 |
Affinity Capture-MS |
|
Homo sapiens |
|
78 |
JMJD6 |
23210 |
Affinity Capture-MS |
|
Homo sapiens |
|
79 |
HIST1H4A |
8359 |
Affinity Capture-MS |
|
Homo sapiens |
|
80 |
RPL9 |
6133 |
Co-fractionation |
|
Homo sapiens |
|
81 |
SRP14 |
6727 |
Affinity Capture-MS |
|
Homo sapiens |
|
82 |
CUL4B |
8450 |
Affinity Capture-MS |
|
Homo sapiens |
|
83 |
RPL4 |
6124 |
Co-fractionation |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
Co-fractionation |
|
Homo sapiens |
Co-fractionation |
|
Homo sapiens |
|
84 |
RPS10 |
6204 |
Co-fractionation |
|
Homo sapiens |
Co-fractionation |
|
Homo sapiens |
|
85 |
TMEM165 |
55858 |
Co-fractionation |
|
Homo sapiens |
|
86 |
DNAJC2 |
27000 |
Affinity Capture-MS |
|
Homo sapiens |
|
87 |
MAPRE1 |
22919 |
Affinity Capture-MS |
|
Homo sapiens |
|
88 |
LRIF1 |
|
Two-hybrid |
|
Homo sapiens |
|
89 |
SRSF6 |
6431 |
Affinity Capture-MS |
|
Homo sapiens |
|
90 |
RPL5 |
6125 |
Co-fractionation |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
91 |
RPL18A |
6142 |
Co-fractionation |
|
Homo sapiens |
|
92 |
CHMP4B |
128866 |
Affinity Capture-MS |
|
Homo sapiens |
|
93 |
FOXL2 |
|
Affinity Capture-Western |
|
Homo sapiens |
|
94 |
BTF3 |
689 |
Affinity Capture-MS |
|
Homo sapiens |
|
95 |
TRIM21 |
6737 |
Affinity Capture-MS |
|
Homo sapiens |
|
96 |
RPL31 |
6160 |
Co-fractionation |
|
Homo sapiens |
|
97 |
RPS7 |
6201 |
Co-fractionation |
|
Homo sapiens |
Co-fractionation |
|
Homo sapiens |
|
98 |
HIST1H1E |
3008 |
Affinity Capture-MS |
|
Homo sapiens |
|
99 |
MOV10 |
4343 |
Co-fractionation |
|
Homo sapiens |
|
100 |
RPL36 |
25873 |
Co-fractionation |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
101 |
ASCC2 |
84164 |
Two-hybrid |
|
Homo sapiens |
|
102 |
ANKRD13B |
|
Two-hybrid |
|
Homo sapiens |
|
103 |
RPL27A |
6157 |
Co-fractionation |
|
Homo sapiens |
|
104 |
RPLP1 |
6176 |
Two-hybrid |
|
Homo sapiens |
Two-hybrid |
|
Homo sapiens |
|
105 |
ANKHD1 |
54882 |
Co-fractionation |
|
Homo sapiens |
|
106 |
PML |
5371 |
Affinity Capture-MS |
|
Homo sapiens |
|
107 |
UBE2D3 |
7323 |
Two-hybrid |
|
Homo sapiens |
|
108 |
GEMIN7 |
|
Two-hybrid |
|
Homo sapiens |
|
109 |
RPLP0 |
6175 |
Co-fractionation |
|
Homo sapiens |
Co-fractionation |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
Co-fractionation |
|
Homo sapiens |
Co-fractionation |
|
Homo sapiens |
Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
110 |
RPLP0P6 |
220717 |
Co-fractionation |
|
Homo sapiens |
|
111 |
MAGEB2 |
4113 |
Affinity Capture-MS |
|
Homo sapiens |
|
112 |
DDX39B |
7919 |
Affinity Capture-MS |
|
Homo sapiens |
|
113 |
SAT1 |
|
Two-hybrid |
|
Homo sapiens |
|
114 |
RPS15A |
6210 |
Co-fractionation |
|
Homo sapiens |
Co-fractionation |
|
Homo sapiens |
|
115 |
SEC61B |
10952 |
Affinity Capture-MS |
|
Homo sapiens |
|
116 |
CYLD |
|
Affinity Capture-MS |
|
Homo sapiens |
|
117 |
LOC101929876 |
101929876 |
Co-fractionation |
|
Homo sapiens |
|
118 |
HMGB2 |
3148 |
Affinity Capture-MS |
|
Homo sapiens |
|
119 |
RPS6KA6 |
27330 |
Two-hybrid |
|
Homo sapiens |
|
120 |
MGMT |
4255 |
Affinity Capture-MS |
|
Homo sapiens |
|
121 |
CDIPT |
10423 |
Two-hybrid |
|
Homo sapiens |
|
122 |
CNBP |
7555 |
| | | |